Neurocrine Biosciences Logo

Neurocrine Biosciences

🇺🇸
NBIX
US64125C1099

Neurocrine Biosciences is a biopharmaceutical company that researches, develops, and markets innovative therapies for neurological, psychiatric, and rare endocrine diseases. The company focuses on improving patients' quality of life through scientific advancements and providing much-needed medicines.

Next Quarterly Earnings

Tuesday, August 4, 2026
CW 32
After-Hours
In 30 days

Stock Price

All Dates

Company Information

Name
Neurocrine Biosciences
Ticker Symbol
NBIX
ISIN
US64125C1099
Country
🇺🇸
USA